RESUMEN
BACKGROUND & AIMS: Wheat has become the world's major staple and its consumption correlates with prevalence of noncommunicable disorders such as inflammatory bowel diseases. Amylase trypsin inhibitors (ATIs), a component of wheat, activate the intestine's innate immune response via toll-like receptor 4 (TLR4). We investigated the effects of wheat and ATIs on severity of colitis and fecal microbiota in mice. METHODS: C57BL/6 wild-type and Tlr4-/- mice were fed wheat- or ATI-containing diets or a wheat-free (control) diet and then given dextran sodium sulfate to induce colitis; we also studied Il10-/- mice, which develop spontaneous colitis. Changes in fecal bacteria were assessed by taxa-specific quantitative polymerase chain reaction and 16S ribosomal RNA metagenomic sequencing. Feces were collected from mice on wheat-containing, ATI-containing, control diets and transplanted to intestines of mice with and without colitis on control or on ATI-containing diets. Intestinal tissues were collected and analyzed by histology, immunohistochemistry, and flow cytometry. Bacteria with reported immunomodulatory effects were incubated with ATIs and analyzed in radial diffusion assays. RESULTS: The wheat- or ATI-containing diets equally increased inflammation in intestinal tissues of C57BL/6 mice with colitis, compared with mice on control diets. The ATI-containing diet promoted expansion of taxa associated with development of colitis comparable to the wheat-containing diet. ATIs inhibited proliferation of specific human commensal bacteria in radial diffusion assays. Transplantation of microbiota from feces of mice fed the wheat- or ATI-containing diets to intestines of mice on control diets increased the severity of colitis in these mice. The ATI-containing diet did not increase the severity of colitis in Tlr4-/- mice. CONCLUSIONS: Consumption of wheat or wheat ATIs increases intestinal inflammation in mice with colitis, via TLR4, and alters their fecal microbiota. Wheat-based, ATI-containing diets therefore activate TLR4 signaling and promote intestinal dysbiosis.
Asunto(s)
Colitis/inmunología , Disbiosis/inmunología , Enfermedades Inflamatorias del Intestino/inmunología , Proteínas de Vegetales Comestibles/efectos adversos , Triticum/inmunología , Alimentación Animal/efectos adversos , Animales , Colitis/inducido químicamente , Colitis/diagnóstico , Colitis/microbiología , Sulfato de Dextran/toxicidad , Modelos Animales de Enfermedad , Disbiosis/complicaciones , Disbiosis/diagnóstico , Disbiosis/microbiología , Trasplante de Microbiota Fecal , Heces/microbiología , Microbioma Gastrointestinal/inmunología , Humanos , Inmunidad Innata , Enfermedades Inflamatorias del Intestino/inducido químicamente , Enfermedades Inflamatorias del Intestino/diagnóstico , Enfermedades Inflamatorias del Intestino/microbiología , Masculino , Ratones , Ratones Noqueados , Proteínas de Vegetales Comestibles/inmunología , Índice de Severidad de la Enfermedad , Transducción de Señal/genética , Transducción de Señal/inmunología , Receptor Toll-Like 4/genética , Receptor Toll-Like 4/metabolismo , Inhibidores de Tripsina/efectos adversos , Inhibidores de Tripsina/inmunologíaRESUMEN
Routine diagnostic methods for allergies to plant-derived foods are based on skin prick test (SPT) with commercial extracts, prick-by-prick (PbP) with fresh food, serum-specific IgE measurement, and oral food challenge.We discuss the possibility and the advantages of performing, in patients with oral allergy syndrome (OAS) by fruit and vegetables (excluding nuts) PR-10 allergy, component-resolved diagnosis (CRD) by SPT and PbP with raw and cooked vegetables, rather than performing a CRD with in vitro tests by drawing blood.Based on our clinical experience and the studies published in the literature, we believe that, at least for the OAS by fruit and vegetables (excluding nuts) PR-10 allergy, the search for sensitizing allergens and related cross-reactive allergens with SPT and PbP can be performed routinely in clinical practice, even at the primary-care level.
Asunto(s)
Alérgenos/efectos adversos , Hipersensibilidad a los Alimentos/diagnóstico , Frutas/efectos adversos , Proteínas de Vegetales Comestibles/efectos adversos , Verduras/efectos adversos , Alérgenos/administración & dosificación , Alérgenos/inmunología , Niño , Reacciones Cruzadas , Femenino , Hipersensibilidad a los Alimentos/inmunología , Frutas/inmunología , Humanos , Proteínas de Vegetales Comestibles/administración & dosificación , Proteínas de Vegetales Comestibles/inmunología , Pruebas Cutáneas , Verduras/inmunologíaRESUMEN
Wheat gluten can be chemically or enzymatically hydrolysed to produce functional ingredients useful in food and cosmetics. However severe allergies to hydrolysed wheat proteins (HWP) have been described in Europe and Japan since the early 2000's. Triggering proteins and IgE epitopes were described both for French and Japanese cohorts and appeared remarkably similar leading to define a new wheat allergic entity. Deamidation induced by functionalisation generate neo-allergens responsible for this particular allergy. This article aims to review the processes leading to deamidation and the clinical features of the patients suffering from this allergy. Then the molecular determinants involved in HWP-allergy were exhaustively described and hypothesis regarding the sensitizing mechanism of HWP-allergy are discussed. Finally, current regulation and tools aiming at managing this risk associated with HWP are presented.
Asunto(s)
Alérgenos , Glútenes/efectos adversos , Proteínas de Vegetales Comestibles/efectos adversos , Hidrolisados de Proteína/efectos adversos , Hipersensibilidad al Trigo , Humanos , Inmunoglobulina E , Estructura Molecular , Triticum/químicaRESUMEN
BACKGROUND AND AIMS: Plant-based protein intake is associated with all-cause and/or cardiovascular disease (CVD) mortality in general population, but such data are scarce in dialysis patients. Thus, we examined the associations of plant-based protein-total protein ratio with all-cause and CVD mortality in patients on peritoneal dialysis (PD). METHODS AND RESULTS: The study enrolled 884 incident patients who started PD between October 2002 and August 2014. All demographic and laboratory data were recorded at baseline. Repeated measurements for laboratory and nutrition parameters were recorded at regular intervals and thus calculated as time-averaged values. Multivariable Cox regression models were used to estimate the hazard ratio (HR) of plant-based protein-total protein ratio and mortality based on baseline and time-averaged covariates, respectively. There were 437 (49%) patients died during a mean follow-up period of 45 months, of which 178 (40.8%) were due to CVD. Each 10% in increase in time-averaged plant-based protein-total protein ratio was associated with a reduction of 71% (95% CI, 90%-14%) and 89% (95% CI, 98%-29%) for all-cause and CVD mortality, respectively. Based on examination on interactive effects, we further found both baseline and time-averaged plant-based protein-total protein ratio were inversely associated with all-cause and CVD mortality in the subgroups of female, age ≥60 years, and albumin >35 g/L. CONCLUSIONS: The present study suggested that a diet with a higher plant-based protein-total protein ratio is associated with lower all-cause and CVD mortality in PD patients, and is more significant in female and elderly patients, and those without hypoalbuminemia.
Asunto(s)
Enfermedades Cardiovasculares/mortalidad , Fallo Renal Crónico/terapia , Diálisis Peritoneal/mortalidad , Proteínas de Vegetales Comestibles/administración & dosificación , Adulto , Factores de Edad , Anciano , Beijing/epidemiología , Enfermedades Cardiovasculares/diagnóstico , Enfermedades Cardiovasculares/prevención & control , Causas de Muerte , Comorbilidad , Femenino , Humanos , Hipoalbuminemia/mortalidad , Fallo Renal Crónico/diagnóstico , Fallo Renal Crónico/mortalidad , Masculino , Persona de Mediana Edad , Estado Nutricional , Diálisis Peritoneal/efectos adversos , Proteínas de Vegetales Comestibles/efectos adversos , Factores Protectores , Estudios Retrospectivos , Medición de Riesgo , Factores de Riesgo , Factores Sexuales , Factores de Tiempo , Resultado del TratamientoRESUMEN
Plant lipid transfer proteins (LTPs) are widespread plant food allergens, highly resistant to food processing and to the gastrointestinal environment, which have been described as the most common food allergens in the Mediterranean area. LTP allergy is widely described in adults, but it represents an emerging allergen also in the pediatric population. Little is known about the real prevalence and the clinical features of this allergy in children and it still often remains underdiagnosed in these patients. An early identification and a deeper knowledge of this allergy in childhood can avoid severe systemic reactions and improve the child's quality of life. Pediatricians should always consider the possibility of LTP involvement in cases of plant-derived food allergy.
Asunto(s)
Alérgenos/efectos adversos , Anafilaxia/inmunología , Antígenos de Plantas/efectos adversos , Proteínas Portadoras/efectos adversos , Hipersensibilidad a los Alimentos/diagnóstico , Proteínas de Vegetales Comestibles/efectos adversos , Proteínas de Plantas/efectos adversos , Alérgenos/inmunología , Anafilaxia/tratamiento farmacológico , Antígenos de Plantas/inmunología , Proteínas Portadoras/inmunología , Niño , Reacciones Cruzadas , Hipersensibilidad a los Alimentos/complicaciones , Hipersensibilidad a los Alimentos/dietoterapia , Hipersensibilidad a los Alimentos/inmunología , Humanos , Inmunoglobulina E/inmunología , Educación del Paciente como Asunto , Proteínas de Plantas/inmunología , Proteínas de Vegetales Comestibles/inmunología , Polen/efectos adversos , Polen/inmunología , Calidad de Vida , Índice de Severidad de la EnfermedadRESUMEN
BACKGROUND: Peanut allergy is a generally persistent, sometimes life-threatening food allergy. With no treatments demonstrating the ability to cure a food allergy, the focus of drugs in development has been on providing a level of protection against accidental exposure reactions. However, no study has estimated the relative risk reduction of a food-allergic population receiving a specific immunotherapeutic treatment for their allergies. OBJECTIVE: To estimate the relative risk reduction when consuming peanut-contaminated packaged food products in a double-blind, placebo-controlled Phase 3 study population of children treated with epicutaneous immunotherapy (EPIT) for 12 months with either a patch containing 250 µg peanut protein (250-µg patch) or a placebo patch. METHODS: The probability of an allergic reaction due to the unintended presence of peanut protein in packaged food products was modeled per study group and food category combination using Monte Carlo simulations. Risks per eating occasion of a contaminated packaged food product and the number of individuals per study population predicted to react on a yearly basis were investigated. RESULTS: The population treated with the 250-µg patch demonstrated a significantly increased dose-response distribution after 12 months of treatment, which resulted in a relative risk reduction of 73.2% to 78.4% when consuming peanut-contaminated packaged food products. In contrast, no statistically significant change was observed for the placebo group at the 12-month point. CONCLUSION: Our study estimates a substantial relative risk reduction for allergic reactions among peanut-allergic children after 12 months of EPIT with the 250-µg patch, supporting the potential real-world clinical relevance of this investigational immunotherapy and its possible role as a future therapy for peanut-allergic children. ClinicalTrials.gov Identifier: NCT02636699.
Asunto(s)
Alérgenos/administración & dosificación , Antígenos de Plantas/administración & dosificación , Arachis , Desensibilización Inmunológica , Hipersensibilidad al Cacahuete/terapia , Proteínas de Vegetales Comestibles/administración & dosificación , Administración Cutánea , Alérgenos/efectos adversos , Antígenos de Plantas/efectos adversos , Arachis/efectos adversos , Niño , Preescolar , Método Doble Ciego , Contaminación de Alimentos , Humanos , Proteínas de Vegetales Comestibles/efectos adversos , Conducta de Reducción del RiesgoRESUMEN
AIM: To compare high animal protein (AP) with high plant protein (PP) diets, differing in amino acid composition, in people with type 2 diabetes (T2DM). MATERIALS AND METHODS: We compared isocaloric diets containing 30% of energy either as AP or PP, using newly developed PP-enriched foods, both combined with 30% energy as fat and 40% as carbohydrates in 44 patients with T2DM over 6 weeks in a randomized parallel-group study. Insulin sensitivity was assessed by hyperinsulinaemic-euglycaemic clamps and cardiovascular variables were measured. RESULTS: Uric acid decreased in both groups, but significantly more in the AP than the PP group. There were no significant differences in other variables, although glycated haemoglobin levels, diastolic blood pressure and fasting non-esterified fatty acid levels improved significantly in the PP but not in the AP group. Insulin sensitivity (M-value), C-reactive protein and fasting glucose improved significantly in the AP but not in the PP group. Total and LDL cholesterol levels and systolic blood pressure decreased significantly in both groups, and the urinary albumin excretion rate decreased from baseline in participants with microalbuminuria. CONCLUSIONS: Isocaloric diets high in AP or PP allow similar improvements in metabolism and cardiovascular risk factors in people with T2DM, indicating that the differences in amino acid composition do not affect the metabolic responses to the interventions.
Asunto(s)
Enfermedades Cardiovasculares/prevención & control , Diabetes Mellitus Tipo 2/dietoterapia , Angiopatías Diabéticas/prevención & control , Cardiomiopatías Diabéticas/prevención & control , Dieta para Diabéticos/métodos , Resistencia a la Insulina , Proteínas de Vegetales Comestibles/administración & dosificación , Anciano , Biomarcadores/sangre , Proteína C-Reactiva/análisis , Enfermedades Cardiovasculares/complicaciones , Enfermedades Cardiovasculares/epidemiología , Estudios de Cohortes , Productos Lácteos/efectos adversos , Diabetes Mellitus Tipo 2/sangre , Diabetes Mellitus Tipo 2/complicaciones , Diabetes Mellitus Tipo 2/metabolismo , Angiopatías Diabéticas/epidemiología , Cardiomiopatías Diabéticas/epidemiología , Femenino , Alemania/epidemiología , Humanos , Hipercolesterolemia/complicaciones , Hipercolesterolemia/epidemiología , Hipercolesterolemia/prevención & control , Hiperglucemia/prevención & control , Masculino , Carne/efectos adversos , Persona de Mediana Edad , Proteínas de Vegetales Comestibles/efectos adversos , Factores de Riesgo , Ácido Úrico/sangreRESUMEN
We previously reported that rice endosperm protein (REP) has renoprotective effects in Goto-Kakizaki rats, a non-obese diabetic model. However, whether these effects occur in obese diabetes remains unclear. This study aimed to clarify the effects of REP on obese diabetes, especially on fatty liver and diabetic nephropathy, using the obese diabetic model Zucker diabetic fatty (ZDF) rats. In total, 7-week-old male ZDF rats were fed diets containing 20 % REP or casein (C) for 8 weeks. Changes in fasting blood glucose levels and urinary markers were monitored during the experimental period. Hepatic lipids and metabolites were measured and renal glomeruli were observed morphologically. HbA1c levels were significantly lower in rats fed REP, compared with C (P<0·05). Compared with C in the liver, REP prevented lipid accumulation (total lipid, TAG and total cholesterol, P<0·01). Liver metabolome analysis indicated that levels of metabolites associated with glycolysis, the pentose phosphate pathway and carnitine metabolism were significantly greater in the REP group than in the C group (P<0·05), suggesting activation of both glucose catabolism and fatty acid oxidation. The metabolite increases promoted by REP may contribute to suppression of liver lipid accumulation. Urinary excretion of albumin and N-acetyl-ß-d-glucosaminidase was significantly reduced in rats fed REP for 8 weeks (P<0·01). In addition, there was a distinct suppression of mesangial matrix expansion and glomerular hypertrophy in response to REP (P<0·01). Thus, REP had preventive effects on obese diabetes, fatty liver and diabetic nephropathy.
Asunto(s)
Diabetes Mellitus Tipo 2/dietoterapia , Nefropatías Diabéticas/dietoterapia , Dieta Vegetariana , Endospermo/química , Enfermedad del Hígado Graso no Alcohólico/dietoterapia , Oryza/química , Proteínas de Vegetales Comestibles/uso terapéutico , Animales , Biomarcadores/sangre , Biomarcadores/metabolismo , Biomarcadores/orina , Errores Innatos del Metabolismo de los Carbohidratos/prevención & control , Diabetes Mellitus Tipo 2/complicaciones , Diabetes Mellitus Tipo 2/metabolismo , Diabetes Mellitus Tipo 2/patología , Nefropatías Diabéticas/complicaciones , Nefropatías Diabéticas/metabolismo , Nefropatías Diabéticas/fisiopatología , Dieta Vegetariana/efectos adversos , Progresión de la Enfermedad , Metabolismo Energético , Glicerol Quinasa/deficiencia , Hiperfosfatemia/etiología , Hiperfosfatemia/prevención & control , Insuficiencia Corticosuprarrenal Familiar , Glomérulos Renales/patología , Glomérulos Renales/fisiopatología , Metabolismo de los Lípidos , Hígado/metabolismo , Hígado/patología , Masculino , Enfermedad del Hígado Graso no Alcohólico/complicaciones , Enfermedad del Hígado Graso no Alcohólico/metabolismo , Enfermedad del Hígado Graso no Alcohólico/fisiopatología , Obesidad/complicaciones , Tamaño de los Órganos , Proteínas de Vegetales Comestibles/efectos adversos , Ratas Zucker , Insuficiencia Renal Crónica/etiología , Insuficiencia Renal Crónica/prevención & control , Aumento de PesoRESUMEN
To solve the future food insecurity problem, alternative and sustainable protein sources (e.g. insects, rapeseed, fava bean and algae) are now being explored for the production of food and feed. To approve these novel protein sources for future food a comprehensive risk assessment is needed according to the European food legislation. Allergenicity risk assessment might pose some major difficulties, since detailed guidance on how to assess the allergenic potential of novel foods is not available. At present, the approach relies mostly on the guidance of allergenicity assessment for genetically modified (GM) plant foods. The most recent one was proposed by EFSA (2010 and 2011); "weight-of-evidence approach". However this guidance is difficult to interpret, not completely applicable or validated for novel foods and therefore needs some adjustments. In this paper we propose a conceptual strategy which is based on the "weight-of-evidence approach" for food derived from GM plants and other strategies that were previously published in the literature. This strategy will give more guidance on how to assess the allergenicity of novel food proteins and protein sources.
Asunto(s)
Alérgenos/efectos adversos , Seguridad de Productos para el Consumidor , Hipersensibilidad a los Alimentos/etiología , Inocuidad de los Alimentos , Alimentos Modificados Genéticamente/efectos adversos , Pruebas Inmunológicas , Proteínas de Vegetales Comestibles/efectos adversos , Plantas Modificadas Genéticamente/efectos adversos , Alérgenos/genética , Alérgenos/inmunología , Animales , Seguridad de Productos para el Consumidor/normas , Reacciones Cruzadas , Hipersensibilidad a los Alimentos/inmunología , Guías como Asunto , Humanos , Pruebas Inmunológicas/normas , Proteínas de Vegetales Comestibles/genética , Proteínas de Vegetales Comestibles/inmunología , Plantas Modificadas Genéticamente/genética , Plantas Modificadas Genéticamente/inmunología , Medición de RiesgoRESUMEN
BACKGROUND: Wheat flour is one of the most common causative agents of food allergy. The study presents the selection and characterization of lactic acid bacteria (LAB) strains capable of hydrolyzing/modifying allergenic proteins of wheat flour. Hydrolysis of wheat proteins was determined with sodium dodecyl sulfate-polyacrylamide gel electrophoresis and immunoblotting with sera from patients with food allergy to gluten. RESULTS: The analysis of electrophoretic profiles of protein extracted from sourdough shows the capability of selected LAB strains for proteolytic degradation of wheat proteins that belong to two factions: albumin/globulin (hydrolysis of 13 polypeptides with a molecular weight between 103 and 22 kDa); and gliadin (seven polypeptides with a molecular weight between 39 and 24 kDa). All analyzed strains were capable of hydrolyzing some IgE-binding epitopes of wheat allergens. The lack of such changes in control samples indicates that they were induced rather by the proteolytic activity of bacterial strains than endogenous enzymes of wheat flour. The gluten proteins were susceptible to hydrolysis by sequential digestion with pepsin and trypsin. CONCLUSION: The selected strains exhibit proteolytic activity, which leads to a reduction in allergenicity of wheat sourdoughs. These strains may be applied as specific starter cultures to prepare bakery products of special nutritional use. © 2015 Society of Chemical Industry.
Asunto(s)
Antígenos de Plantas/metabolismo , Pan/análisis , Dieta Sin Gluten , Harina/análisis , Glútenes/metabolismo , Lactobacillales/metabolismo , Proteínas de Vegetales Comestibles/metabolismo , Albúminas/efectos adversos , Albúminas/química , Albúminas/metabolismo , Antígenos de Plantas/efectos adversos , Antígenos de Plantas/química , Pan/efectos adversos , Pan/microbiología , Epítopos/efectos adversos , Epítopos/metabolismo , Fermentación , Harina/efectos adversos , Harina/microbiología , Gliadina/efectos adversos , Gliadina/química , Gliadina/metabolismo , Globulinas/efectos adversos , Globulinas/química , Globulinas/metabolismo , Glútenes/efectos adversos , Humanos , Lactobacillales/crecimiento & desarrollo , Lactobacillales/aislamiento & purificación , Peso Molecular , Proteínas de Vegetales Comestibles/efectos adversos , Proteínas de Vegetales Comestibles/química , Polonia , Proteolisis , Semillas/efectos adversos , Semillas/química , Semillas/microbiología , Especificidad de la Especie , Triticum/efectos adversos , Triticum/química , Triticum/microbiología , Hipersensibilidad al Trigo/dietoterapia , Hipersensibilidad al Trigo/inmunologíaRESUMEN
PURPOSE: Hyperuricemia is a recognized risk factor for cardiovascular diseases. Soy foods contain a moderate amount of purine and may predispose to raised serum uric acid (UA). However, no study has examined the long-term effect of soy intake on UA levels. We examined whether consumption of soy foods and isoflavone extracts for 6 months altered serum UA. METHODS: The analysis included two randomized controlled trials (soy protein trial and whole soy trial) among total 450 postmenopausal women with either prehypertension or prediabetes. We conducted a pooled analysis by combining participants from both the soy flour and soy protein groups (combined soy foods group), participants from both the isoflavone and daidzein groups (combined isoflavone group) and participants from both milk placebo groups. Fasting venous samples were obtained at baseline and the end of the trial for serum UA analysis. RESULTS: In the pooled data, 417 subjects completed the study according to protocol. The baseline serum UA levels were comparable among the three combined groups. There was a lower decrease in UA levels among women in the combined soy foods group compared with women in the other two groups (p = 0.028 and 0.026). The net decrease and % decrease in UA were 14.5 µmol/L (95 % CI 1.93-25.6, p = 0.023) or 4.9 % (95 % CI 1.3-8.5 %, p = 0.023) between the combined soy foods group and placebo group. CONCLUSIONS: Among Chinese postmenopausal women with either prehypertension or prediabetes, soy intake did not increase urate levels.
Asunto(s)
Envejecimiento , Enfermedades Cardiovasculares/prevención & control , Hiperuricemia/prevención & control , Proteínas de Vegetales Comestibles/uso terapéutico , Alimentos de Soja , Proteínas de Soja/uso terapéutico , Ácido Úrico/sangre , Anciano , Enfermedades Cardiovasculares/etiología , China/epidemiología , Suplementos Dietéticos/efectos adversos , Método Doble Ciego , Femenino , Humanos , Hiperuricemia/sangre , Hiperuricemia/etiología , Hiperuricemia/fisiopatología , Isoflavonas/efectos adversos , Isoflavonas/uso terapéutico , Metaanálisis como Asunto , Persona de Mediana Edad , Proteínas de Vegetales Comestibles/efectos adversos , Posmenopausia , Estado Prediabético/dietoterapia , Estado Prediabético/fisiopatología , Prehipertensión/dietoterapia , Prehipertensión/fisiopatología , Factores de Riesgo , Alimentos de Soja/efectos adversos , Proteínas de Soja/efectos adversosRESUMEN
Plant allergens, being one of the most widespread allergenic substances, are hard to avoid. Hence, their identification and characterization are of prime importance for the diagnosis and treatment of food allergy. The reported allergies to fruits mainly evoke oral allergy syndrome caused by the presence of cross-reactive IgE to certain pollens and thus, allergy to fruits has also been linked to particular pollens. Many fruit allergies are being studied for their causative allergens, and are being characterized. Some tropical or exotic fruits are responsible for region-specific allergies for which only limited information is available, and generally lack allergen characterization. From a survey of the literature on fruit allergy, it is clear that some common fruits (apple, peach, musk melon, kiwi fruit, cherry, grape, strawberry, banana, custard apple, mango and pomegranate) and their allergens appear to be at the center of current research on food allergy. The present review focuses on common fruits reported as allergenic and their identified allergens; a brief description of allergens from six rare/tropical fruits is also covered.
Asunto(s)
Alérgenos/efectos adversos , Hipersensibilidad a los Alimentos/inmunología , Frutas/efectos adversos , Proteínas de Vegetales Comestibles/efectos adversos , Alérgenos/sangre , Alérgenos/inmunología , Especificidad de Anticuerpos , Biomarcadores/sangre , Reacciones Cruzadas , Hipersensibilidad a los Alimentos/diagnóstico , Hipersensibilidad a los Alimentos/epidemiología , Hipersensibilidad a los Alimentos/terapia , Frutas/inmunología , Humanos , Inmunoglobulina E/sangre , Proteínas de Vegetales Comestibles/inmunología , Polen/inmunología , Valor Predictivo de las Pruebas , Pronóstico , Factores de Riesgo , Pruebas CutáneasRESUMEN
Dietary protein has been shown to increase urinary Ca excretion in randomised controlled trials, and diets high in protein may have detrimental effects on bone health; however, studies examining the relationship between dietary protein and bone health have conflicting results. In the present study, we examined the relationship between dietary protein (total, animal and vegetable protein) and lumbar spine trabecular volumetric bone mineral density (vBMD) among participants enrolled in the Multi-Ethnic Study of Atherosclerosis (n 1658). Protein intake was assessed using a FFQ obtained at baseline examination (2000-2). Lumbar spine vBMD was measured using quantitative computed tomography (2002-5), on average 3 years later. Multivariable linear and robust regression techniques were used to examine the associations between dietary protein and vBMD. Sex and race/ethnicity jointly modified the association of dietary protein with vBMD (P for interaction = 0·03). Among white women, higher vegetable protein intake was associated with higher vBMD (P for trend = 0·03), after adjustment for age, BMI, physical activity, alcohol consumption, current smoking, educational level, hormone therapy use, menopause and additional dietary factors. There were no consistently significant associations for total and animal protein intakes among white women or other sex and racial/ethnic groups. In conclusion, data from the present large, multi-ethnic, population-based study suggest that a higher level of protein intake, when substituted for fat, is not associated with poor bone health. Differences in the relationship between protein source and race/ethnicity of study populations may in part explain the inconsistent findings reported previously.
Asunto(s)
Dieta/efectos adversos , Proteínas en la Dieta/efectos adversos , Osteoporosis/etiología , Anciano , Anciano de 80 o más Años , Densidad Ósea , Estudios de Cohortes , Dieta/etnología , Femenino , Estudios de Seguimiento , Humanos , Vértebras Lumbares/diagnóstico por imagen , Masculino , Persona de Mediana Edad , Osteoporosis/diagnóstico por imagen , Osteoporosis/epidemiología , Osteoporosis/etnología , Proteínas de Vegetales Comestibles/efectos adversos , Riesgo , Factores Sexuales , Encuestas y Cuestionarios , Tomografía Computarizada por Rayos X , Estados Unidos/epidemiología , Población BlancaRESUMEN
BACKGROUND: Peanut allergy is the leading cause of food-related anaphylaxis, and accidental exposures are common. Oral immunotherapy (OIT) has been posited as a potential treatment. METHODS: Patients aged 3-65 years with peanut-specific IgE ≥7 kU/l and/or a positive skin prick test with a history of an allergic reaction to peanut were recruited to undergo an OIT protocol. All adverse reactions were recorded by research staff or patients in real time. RESULTS: Twenty-four patients received 6,662 doses. Symptoms were mostly mild (84%), and only 3 severe gastrointestinal reactions required the administration of epinephrine. Abdominal pain was the most common reaction, followed by oropharyngeal and lip pruritus. Respiratory symptoms were rare. CONCLUSIONS: In this trial of OIT in adults and children, most reactions were mild.
Asunto(s)
Desensibilización Inmunológica/efectos adversos , Hipersensibilidad al Cacahuete/terapia , Administración Oral , Adolescente , Adulto , Alérgenos/administración & dosificación , Alérgenos/efectos adversos , Arachis/efectos adversos , Arachis/inmunología , Niño , Preescolar , Desensibilización Inmunológica/métodos , Femenino , Humanos , Inmunoglobulina E/sangre , Masculino , Persona de Mediana Edad , Hipersensibilidad al Cacahuete/diagnóstico , Hipersensibilidad al Cacahuete/inmunología , Proteínas de Vegetales Comestibles/administración & dosificación , Proteínas de Vegetales Comestibles/efectos adversos , Seguridad , Pruebas CutáneasRESUMEN
BACKGROUND: Seed storage proteins (SSP; Ara h 1, Ara h 2, Ara h 3) have been shown to be major peanut allergens, although recently, peanut lipid transfer protein has been reported to be an important allergen in the Mediterranean area. We sought to investigate the sensitization pattern to peanut SSP and vegetable pan-allergens in a group of peanut-allergic children compared with a peanut-tolerant group. METHODS: One hundred and twenty-three children who presented with food allergy were included in the study. Tolerance to peanut ingestion was assessed. Specific IgE was determined by ImmunoCAP, and microarray ISAC was performed. Sensitization frequencies and levels of specific IgE were compared between groups. RESULTS: Fifty-five of 123 children presented symptoms upon contact or ingestion. Frequency of sensitization to Ara h 1, Ara h 2, and Ara h 3 was 60.0%, 72.7%, and 43.6%, respectively, in the group of allergic children vs. 7.4%, 1.5%, and 7.4% in the group of tolerant children. Levels of specific IgE against Ara h 1, Ara h 2, and Ara h 3 were significantly higher in the allergic group (p < 0.001). The frequency of sensitization and the levels of specific IgE against Cor a 8 (36.4% vs. 16.2%) were significantly higher in the allergic children, whereas no significant differences were found for Pru p 3. No differences were seen for other pan-allergens. Patients sensitized to SSP, regardless of sensitization to nsLTP, were allergic rather than tolerant. CONCLUSION: In our population, peanut-allergic children were mainly sensitive to SSP. A few patients were also sensitive to some nsLTPs. No differences were shown in other pan-allergens.
Asunto(s)
Alérgenos/inmunología , Arachis/efectos adversos , Hipersensibilidad al Cacahuete/inmunología , Proteínas de Vegetales Comestibles/inmunología , Proteínas de Almacenamiento de Semillas/inmunología , Alérgenos/efectos adversos , Niño , Preescolar , Femenino , Humanos , Tolerancia Inmunológica , Inmunización , Inmunoglobulina E/sangre , Masculino , Hipersensibilidad al Cacahuete/diagnóstico , Hipersensibilidad al Cacahuete/epidemiología , Proteínas de Vegetales Comestibles/efectos adversos , Prevalencia , Proteínas de Almacenamiento de Semillas/efectos adversos , Semillas/efectos adversos , EspañaAsunto(s)
Anafilaxia/inmunología , Hipersensibilidad a los Alimentos/inmunología , Proteínas de Vegetales Comestibles/efectos adversos , Vicia faba/efectos adversos , Anafilaxia/diagnóstico , Anafilaxia/tratamiento farmacológico , Antialérgicos/uso terapéutico , Biomarcadores/sangre , Preescolar , Culinaria , Epítopos , Hipersensibilidad a los Alimentos/diagnóstico , Hipersensibilidad a los Alimentos/tratamiento farmacológico , Humanos , Inmunoglobulina E/sangre , Inmunoglobulina E/inmunología , Pruebas Intradérmicas , Masculino , Proteínas de Vegetales Comestibles/inmunología , Pruebas Serológicas , Resultado del Tratamiento , Vicia faba/inmunologíaRESUMEN
Infants diagnosed with allergy to cow's milk protein (CMP) are fed extensively hydrolysed cow's milk formulas, modified soy formulas or even amino acid-based formulas. Hydrolysed rice protein infant formulas have become available and have been shown to be well tolerated by these infants. A prospective open, randomized clinical study to compare the clinical tolerance of a new hydrolysed rice protein formula (HRPF) with an extensively hydrolysed CMP formula (EHF) in the feeding of infants with IgE-mediated cow's milk allergy. Ninety-two infants (46 boys and 46 girls, mean age 4.3 months, range 1.1-10.1 months) diagnosed with IgE-mediated cow's milk allergy were enrolled in the study. Clinical tolerance to the formula products was tested. Clinical evaluation included skin prick tests with whole cow's milk, soya and rice as well as antigens of CMP (beta-lactoglobulin, alpha-lactalbumin, casein and bovine seroalbumin), HRPF and EHF and specific IgE determinations to CMP using CAP technology. Patients were randomized to receive either an EHF based on CMP or a new HRPF. Follow-up was at 3, 6, 12, 18 and 24 months. Growth parameters were measured at each visit. One infant showed immediate allergic reaction to EHF, but no reaction was shown by any infant in the HRPF group. The number of infants who did not become tolerant to CMP during the study was not statistically different between the two groups. Measurement of IgE levels of infants allergic to CMP during the study showed no significant differences between the two formula groups. Growth parameters were in the normal range and similar between groups. In this study, the HRPF was well tolerated by infants with moderate to severe symptoms of IgE-mediated CMP allergy. Children receiving this formula showed similar growth and development of clinical tolerance to those receiving an EHF. In accordance with current guidelines, this HRPF was tolerated by more than 90% of children with CMP allergy and therefore could provide an adequate and safe alternative to CMP-hydrolysed formulas for these infants.
Asunto(s)
Alérgenos/efectos adversos , Fórmulas Infantiles/administración & dosificación , Hipersensibilidad a la Leche/dietoterapia , Proteínas de la Leche/efectos adversos , Proteínas de Vegetales Comestibles/administración & dosificación , Hidrolisados de Proteína/administración & dosificación , Animales , Bovinos , Femenino , Estudios de Seguimiento , Humanos , Tolerancia Inmunológica , Inmunoglobulina E/sangre , Lactante , Fórmulas Infantiles/química , Masculino , Hipersensibilidad a la Leche/sangre , Hipersensibilidad a la Leche/diagnóstico , Hipersensibilidad a la Leche/fisiopatología , Oryza/inmunología , Proteínas de Vegetales Comestibles/efectos adversos , Proteínas de Vegetales Comestibles/química , Estudios Prospectivos , Hidrolisados de Proteína/efectos adversos , Hidrolisados de Proteína/química , Pruebas CutáneasRESUMEN
Analytical methods are needed for measuring the levels of protein from allergenic food transferred into cooking oil. A simple method for determination of total protein in cooking oils was developed. Oil was extracted with phosphate-buffered saline with 0.05% Tween (PBST) and the extracts were partitioned with hexane to remove residual oil. Total protein in the PBST extracts was assayed with bicinchoninic acid (BCA), micro-BCA, reducing-agent compatible BCA and CB-XT kits. These methods were used to measure recovery of protein from peanut butter spikes of soy and peanut oil in the range of 50-1000 ppm. Recoveries were generally above 70%. However, the BCA and micro-BCA assays were subject to interference and enhanced color formation which were probably due to co-extracted antioxidants present in oil. The reducing agent-compatible BCA and CB-X protein assays reduced interference and gave lower protein values in crude, cold-pressed, and refined peanut oils. Heating oil to 180 degrees C before extraction also reduced interference-induced color enhancement. A commercial ELISA test kit was also used to measure peanut protein in oil spiked with peanut butter. Recovery of peanut residues measured by ELISA was significantly decreased when the peanut butter-spiked oil was heated to 180 degrees C compared to unheated oil. Recovery of spiked peanut butter protein measured by the buffer extraction-colorimetric method was not decreased in heated oil. The method developed here could be used to determine protein levels in crude and refined oil, and to assess the potential for allergen cross-contact from reused cooking oil.
Asunto(s)
Antígenos de Plantas/análisis , Análisis de los Alimentos/métodos , Aceites de Plantas/química , Proteínas de Vegetales Comestibles/análisis , Proteínas de Vegetales Comestibles/inmunología , Aceite de Soja/química , Proteínas de Soja/análisis , Colorimetría/métodos , Ensayo de Inmunoadsorción Enzimática/métodos , Contaminación de Alimentos/análisis , Hipersensibilidad a los Alimentos , Calor , Humanos , Aceite de Cacahuete , Proteínas de Vegetales Comestibles/efectos adversos , Proteínas de Soja/efectos adversos , Proteínas de Soja/inmunologíaRESUMEN
OBJECTIVE: To observe the expression patterns of salivary mRNA 21 in different stages and grades of OSMF and also in habitual areca nut chewers without OSMF. SUBJECTS AND METHODS: The study consisted of a total of 185 samples, where 61 patients had chewing habits (chewing gutkha and other forms of areca nut) and had OSMF (Group 1). 61 patients had chewing habits but did not have OSMF (Group 2), and 63 were normal healthy patients (control group) without any chewing habits (Group 3). Unstimulated saliva samples were collected from patients following the standard operating procedures. miRNA 21 was isolated and purified from saliva samples using the miRNeasy Mini Kit, Qiagen. The primers for miRNA relative quantification analysis were designed using the Primer Express software of Applied Biosystems. Quantification of all the samples was carried out using SYBR chemistry in an Applied Biosystems Real-Time PCR. RESULTS: There was no statistically significant difference between the demographic characteristics of patients. There was a statistically significant difference between the expressions of miRNA 21 amongst the three groups noted in Kruskal Wallis test. (<0.001*) A post hoc test was perfomed to confirm the statistical difference between patients within all three groups. There was no statistically significant difference noted between the OSMF group and patients with chewing habits group (G1 vs. G2 p: 0.10), but there was a significant difference when compared with normal patients. (G1 vs. G3 p: <0.001*) and (G2 vs. G3 <0.001*). CONCLUSION: This study concludes that miRNA 21 is overexpressed in OSMF and chewing habit patients. But the expression levels were not significantly associated with the severity of the disease process. A long term and large scale studies are required to assess its application as a diagnostic profibrotic marker in OSMF.
Asunto(s)
Areca/química , MicroARNs/genética , Fibrosis de la Submucosa Bucal/inducido químicamente , Fibrosis de la Submucosa Bucal/genética , Saliva/metabolismo , Expresión Génica/genética , Humanos , Masticación , Proteínas de Vegetales Comestibles/efectos adversosRESUMEN
PURPOSE OF REVIEW: The route of allergen sensing via the skin appears to influence the immune system towards mounting a type 2 response, especially in genetically predisposed individuals. Allergens recognized this way may derive from microbial, animal, food, or other plant sources and trigger atopic dermatitis. Allergens can be grouped into families depending on their structure and function, harboring significant structural and sequence similarities. Cross-reactivity between allergens is believed to arise as a consequence, and to underlie the development of further atopic diseases. RECENT FINDINGS: Especially for the plant allergens of the families of PR10-related proteins and profilins, immune cross-reactions have been described. Actual studies support that food and pollen allergens can aggravate skin lesions in patients suffering from atopic dermatitis. Further on, allergens derived from air-borne or skin-borne fungi belong to common allergen families and bear cross-reactivity potential. Cross-reactivity to human homologous proteins, so-called autoallergens, is discussed to contribute to the chronification of atopic dermatitis. SUMMARY: Due to high evolutionary conservation, allergic reactions can be triggered by highly homologous members of allergen families on the humoral as well as on the cellular level.